Evidence map›Paper›PMID 25781956›Full record

ArticlePloS one2015

Utilizing targeted mass spectrometry to demonstrate Asf1-dependent increases in residue specificity for Rtt109-Vps75 mediated histone acetylation.

Yin-Ming Kuo, Ryan A Henry, Liangqun Huang, Xu Chen, Laurie A Stargell, Andrew J Andrews

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yin-Ming KuoDepartment of Cancer Biology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America.
Ryan A HenryDepartment of Cancer Biology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America.
Liangqun HuangDepartment of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado, United States of America.
Xu ChenDepartment of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado, United States of America.
Laurie A StargellDepartment of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado, United States of America.
Andrew J AndrewsDepartment of Cancer Biology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America.
Colorado State University · USFox Chase Cancer Center · US

Funding

TRAINING PROGRAM IN CANCER RESEARCHT32CA009035 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI CHERNOFF, JONATHAN · 1985 to 2020
$10.5M
project 3P01GM088409 · NIGMS · COLORADO STATE UNIVERSITY · PI NYBORG, JENNIFER K. · 2010 to 2014
$7.3M
The Role of Histone Chaperones in Histone Acetylation and Nucleosome DynamicsR01GM102503 · NIGMS · UNIVERSITY OF NORTH CAROLINA WILMINGTON · PI ANDREWS, ANDREW JOSEPH · 2014 to 2023
$3.9M
NCI NIH HHS T32 CA009035NIGMS NIH HHS GM088409NIGMS NIH HHS P01 GM088409NIGMS NIH HHS R01 GM102503NIGMS NIH HHS R01GM102503
6 · The paper itself

Abstract

In Saccharomyces cerevisiae, Rtt109, a lysine acetyltransferase (KAT), associates with a histone chaperone, either Vps75 or Asf1. It has been proposed that these chaperones alter the selectivity of Rtt109 or which residues it preferentially acetylates. In the present study, we utilized a label-free quantitative mass spectrometry-based method to determine the steady-state kinetic parameters of acetylation catalyzed by Rtt109-Vps75 on H3 monomer, H3/H4 tetramer, and H3/H4-Asf1 complex. These results show that among these histone conformations, only H3K9 and H3K23 are significantly acetylated under steady-state conditions and that Asf1 promotes H3/H4 acetylation by Rtt109-Vps75. Asf1 equally increases the Rtt109-Vps75 specificity for both of these residues with a maximum stoichiometry of 1:1 (Asf1 to H3/H4), but does not alter the selectivity between these two residues. These data suggest that the H3/H4-Asf1 complex is a substrate for Rtt109-Vps75 without altering selectivity between residues. The deletion of either Rtt109 or Asf1 in vivo results in the same reduction of H3K9 acetylation, suggesting that Asf1 is required for efficient H3K9 acetylation both in vitro and in vivo. Furthermore, we found that the acetylation preference of Rtt109-Vps75 could be directed to H3K56 when those histones already possess modifications, such as those found on histones purified from chicken erythrocytes. Taken together, Vps75 and Asf1 both enhance Rtt109 acetylation for H3/H4, although via different mechanisms, but have little impact on the residue selectivity. Importantly, these results provide evidence that histone chaperones can work together via interactions with either the enzyme or the substrate to more efficiently acetylate histones.

Indexed as

AcetylationAnimalsBiocatalysisCell Cycle ProteinsHistone AcetyltransferasesHistonesLysineMass SpectrometryMolecular ChaperonesSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSubstrate SpecificityASF1 protein, S cerevisiaeCell Cycle ProteinsHistone AcetyltransferasesHistonesLysineMolecular ChaperonesRtt109 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsVps75 protein, S cerevisiae

Identifiers

PMID25781956
PMCPMC4364511
OpenAlexW1995492126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.